HIMS Jan 2025 10.000 put
| Previous close | 0.7100 |
| Open | 0.6000 |
| Bid | 0.4500 |
| Ask | 0.5000 |
| Strike | 10.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.4800 - 0.6000 |
| Contract range | N/A |
| Volume | |
| Open interest | 1.72k |
- Yahoo Finance Video
Weight loss: Hims & Hers introduce access to GLP-1 injections
Hims & Hers Health (HIMS) stock has jumped up upon the telehealth provider introducing compounding injectable GLP-1 weight-loss drugs to its services. The Morning Brief's Seana Smith and Brad Smith report on Hims & Hers' latest offering in the weigh-loss drug category. For more expert insight and the latest market action, click here to watch this full episode of Morning Brief. This post was written by Luke Carberry Mogan.
Business WireHims & Hers Announces Access to GLP-1 Injections, Passing Cost Savings Onto Customers
SAN FRANCISCO, May 20, 2024--Hims & Hers Health, Inc., the leading health and wellness platform, today announced the addition of GLP-1 injections to its comprehensive weight loss portfolio, giving customers an affordable way to consistently access safe, high-quality weight loss treatment.
Business WireHims & Hers Welcomes Anja Manuel, Foreign Policy Expert, Domestic Regulations Advisor, and Former Diplomat to its Board of Directors
SAN FRANCISCO, May 16, 2024--Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform, today announced the appointment of Anja Manuel to the company’s Board of Directors. Ms. Manuel is a co-founder and principal in Rice, Hadley, Gates & Manuel LLC, a strategic consulting firm founded in 2009 that helps U.S. companies navigate international markets and regulatory issues, and a former U.S. government official.
